Insulin potentiating peptides

Details for Australian Patent Application No. 2001243942 (hide)

Owner Metabolic Pharmaceuticals Limited

Inventors Ng, Frank Man-Woon; Jiang, Woei-Ji

Agent Griffith Hack

Pub. Number AU-B-2001243942

PCT Pub. Number WO01/72770

Priority PQ6618 31.03.00 AU

Filing date 30 March 2001

Wipo publication date 8 October 2001

Acceptance publication date 16 December 2004

International Classifications

C07K 005/10 Peptides having up to four amino acids in a fully defined sequence

A61K 038/08 Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 038/07 Medicinal preparations containing peptides - Tetrapeptides

C07K 007/04 Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

16 December 2004 Application Accepted

  Published as AU-B-2001243942

14 April 2005 Standard Patent Sealed

23 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001243943-Plant anthocyanidin rutinoside aromatic acyl transferases

2001243941-A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide